Talley, N.J.; et al. (setembro de 1999). BMJ Publishing Group Ltd & British Society of Gastroenterology, ed. «Functional gastroduodenal disorders». GUT
cibersaude.com.br
Barbuti, Ricardo C. (fevereiro de 2009). Departamento de Gastroenterologia – Grupos de Esôfago e Estômago - Faculdade de Medicina da Universidade de São Paulo, ed. «Dispepsia funcional / Functional dyspepsia». RBM rev. bras. med arquivado no Lilacs S0034-72642009001400001. 507652[ligação inativa]
Melzer J, Rösch W, Reichling J, Brignoli R, Saller R (2004). «Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)». Aliment. Pharmacol. Ther. 20 (11-12): 1279–87. PMID15606389. doi:10.1111/j.1365-2036.2004.02275.x !CS1 manut: Nomes múltiplos: lista de autores (link)
Rösch W, Vinson B, Sassin I (2002). «A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia». Z Gastroenterol. 40 (6): 401–8. PMID12055663. doi:10.1055/s-2002-32130 !CS1 manut: Nomes múltiplos: lista de autores (link)
Meineche-Schmidt V, Talley NJ, Pap A; et al. (1999). «Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study». Scand. J. Gastroenterol. 34 (6): 566–74. PMID10440605. doi:10.1080/003655299750026010 !CS1 manut: Nomes múltiplos: lista de autores (link)
Drossman DA. (abril de 2006). Division of Gastroenterology and Hepatology, UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill - Chapel Hill, North Carolina 27599-7080, ed. «The functional gastrointestinal disorders and the Rome III process». Official journal of the AGA institute. PMID16678553 !CS1 manut: Nomes múltiplos: lista de editores (link)
The Guideline Development Group (GDG) oversees the development process (2004). «Clinical guideline 17: Dyspepsia». London. National Institute for Health and Clinical Excellence
Drossman DA. (abril de 2006). Division of Gastroenterology and Hepatology, UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill - Chapel Hill, North Carolina 27599-7080, ed. «The functional gastrointestinal disorders and the Rome III process». Official journal of the AGA institute. PMID16678553 !CS1 manut: Nomes múltiplos: lista de editores (link)
Ford AC, Moayyedi P (2013). "Dysepsia". BMJ. 29: 347. doi:10.1136/bmj.f5059. PMID 23990632.
Melzer J, Rösch W, Reichling J, Brignoli R, Saller R (2004). «Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)». Aliment. Pharmacol. Ther. 20 (11-12): 1279–87. PMID15606389. doi:10.1111/j.1365-2036.2004.02275.x !CS1 manut: Nomes múltiplos: lista de autores (link)
Rösch W, Vinson B, Sassin I (2002). «A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia». Z Gastroenterol. 40 (6): 401–8. PMID12055663. doi:10.1055/s-2002-32130 !CS1 manut: Nomes múltiplos: lista de autores (link)
Meineche-Schmidt V, Talley NJ, Pap A; et al. (1999). «Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study». Scand. J. Gastroenterol. 34 (6): 566–74. PMID10440605. doi:10.1080/003655299750026010 !CS1 manut: Nomes múltiplos: lista de autores (link)